Related Experiment Video
Updated: Jun 18, 2026
05:55
Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats
Published on: September 27, 2024
Dosing-time dependent effect of dexamethasone on bone density in rats
Masaki Takahashi1, Kentarou Ushijima, Yohei Hayashi
1Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University, Tochigi 329-0498, Japan.
Life Sciences
|November 12, 2009
Summary
Optimizing glucocorticoid dosing time can impact bone density. Administering dexamethasone during a resting period may reduce bone loss compared to an active period.
Area of Science:
- Endocrinology
- Bone Biology
- Pharmacology
Background:
- Glucocorticoids are essential medications but can lead to adverse effects like bone fractures.
- Understanding factors influencing glucocorticoid-induced bone loss is crucial for patient safety.
Purpose of the Study:
- To investigate if optimizing the timing of glucocorticoid administration can mitigate decreased bone density.
- To determine the effect of dosing time on dexamethasone-induced bone changes in rats.
Main Methods:
- Rats received daily oral dexamethasone (1mg/kg) for six weeks.
- Dosing occurred during either a resting (2 HALO) or active (14 HALO) period.
- Measurements included femur bone density, bone formation/resorption biomarkers, and histomorphometry.
Main Results:
- Dexamethasone significantly decreased femur bone density.
- Bone density loss was greater when dexamethasone was administered during the active period (14 HALO).
- Dexamethasone suppressed bone resorption more significantly during the resting period (2 HALO).
Conclusions:
- Glucocorticoid-induced bone density reduction is influenced by administration timing.
- Dosing time represents a potential strategy to manage glucocorticoid-related bone complications.
Related Concept Videos
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
01:01Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...